Oruka Therapeutics, Inc. ($ORKA)
Filing Information
| Accession Number | 0000907654-26-000088 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 1, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
15,000
Total Value
$498,101.20
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | Sep 1, 2026 | Exercise/Conversion | 5,000 | $7.80 | $39,000.00 | 241,384 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Sep 1, 2026 | Sale | 1,000 | $91.05 | $91,047.60 | 240,384 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Sep 1, 2026 | Sale | 4,000 | $92.01 | $368,053.60 | 236,384 | Direct | โ | View Details | |
Chief Operating Officer | Employee Warrant (right to buy) | Derivative | Sep 1, 2026 | Exercise/Conversion | 5,000 | $0.00 | $0.00 | 74,996 | Direct | โ | View Details |